TY - JOUR
T1 - Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development
T2 - An International Consensus Statement
AU - Abu-Raya, Bahaa
AU - Maertens, Kirsten
AU - Edwards, Kathryn M.
AU - Omer, Saad B.
AU - Englund, Janet A.
AU - Flanagan, Katie L.
AU - Snape, Matthew D.
AU - Amirthalingam, Gayatri
AU - Leuridan, Elke
AU - Damme, Pierre Van
AU - Papaevangelou, Vana
AU - Launay, Odile
AU - Dagan, Ron
AU - Campins, Magda
AU - Cavaliere, Anna Franca
AU - Frusca, Tiziana
AU - Guidi, Sofia
AU - O'Ryan, Miguel
AU - Heininger, Ulrich
AU - Tan, Tina
AU - Alsuwaidi, Ahmed R.
AU - Safadi, Marco A.
AU - Vilca, Luz M.
AU - Wanlapakorn, Nasamon
AU - Madhi, Shabir A.
AU - Giles, Michelle L.
AU - Prymula, Roman
AU - Ladhani, Shamez
AU - Martinón-Torres, Federico
AU - Tan, Litjen
AU - Michelin, Lessandra
AU - Scambia, Giovanni
AU - Principi, Nicola
AU - Esposito, Susanna
AU - on behalf of World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Vaccine Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EVASG)
PY - 2020/6/24
Y1 - 2020/6/24
N2 - Immunization during pregnancy has been recommended in an increasing number of countries. The aim of this strategy is to protect pregnant women and infants from severe infectious disease, morbidity and mortality and is currently limited to tetanus, inactivated influenza, and pertussis-containing vaccines. There have been recent advancements in the development of vaccines designed primarily for use in pregnant women (respiratory syncytial virus and group B Streptococcus vaccines). Although there is increasing evidence to support vaccination in pregnancy, important gaps in knowledge still exist and need to be addressed by future studies. This collaborative consensus paper provides a review of the current literature on immunization during pregnancy and highlights the gaps in knowledge and a consensus of priorities for future research initiatives, in order to optimize protection for both the mother and the infant.
AB - Immunization during pregnancy has been recommended in an increasing number of countries. The aim of this strategy is to protect pregnant women and infants from severe infectious disease, morbidity and mortality and is currently limited to tetanus, inactivated influenza, and pertussis-containing vaccines. There have been recent advancements in the development of vaccines designed primarily for use in pregnant women (respiratory syncytial virus and group B Streptococcus vaccines). Although there is increasing evidence to support vaccination in pregnancy, important gaps in knowledge still exist and need to be addressed by future studies. This collaborative consensus paper provides a review of the current literature on immunization during pregnancy and highlights the gaps in knowledge and a consensus of priorities for future research initiatives, in order to optimize protection for both the mother and the infant.
KW - group B Streptococcus vaccines
KW - influenza
KW - maternal immunization
KW - pertussis
KW - pregnant women
KW - respiratory syncytial virus
KW - tetanus
UR - http://www.scopus.com/inward/record.url?scp=85087666569&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2020.01282
DO - 10.3389/fimmu.2020.01282
M3 - Review Article
C2 - 32670282
AN - SCOPUS:85087666569
SN - 1664-3224
VL - 11
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 1282
ER -
